Category: Health

Categories
Health

Serving to Runners With Lengthy Covid Get Again on Their Toes

Helping Runners With Long Covid Get Back on Their Feet

Penn developed a physical therapy program that varies depending on the severity of each patient’s symptoms. “For some patients who have been really seriously affected and unable to engage in activities, how do we go back to the housework that they have to do every day? How do we manage this during the day so that you don’t have to do everything at once? “

For those with less severe symptoms, the focus is on gradually getting active again and keeping the heart rate at 60 to 70 percent of its maximum for the time being. “If they tolerate it and agree to it for a week or two, we’ll build on it,” he said.

Long-distance Covid patients tend to “have a honeymoon, maybe two or three weeks after the acute illness,” said Dr. R. Kannan Mutharasan, cardiologist at Northwestern Memorial Hospital in Chicago and co-program director of exercise cardiology. “You’re finally feeling back to yourself and saying, ‘I’m going to run,'” he said. But afterwards they notice that they don’t feel like they used to. A few weeks later, they may experience “things like lightheadedness or a fast heartbeat even while walking.”

That happened to one of his patients, Hannah Engle, 23, who was diagnosed with Covid-19 last July. She tried running again in October and her heart rate rose to 210 beats per minute. She is now on her way to take it slow, but there are still setbacks if she overdoes it. For example, in May, after a seemingly simple exercise with jumping jacks and stretching, she began to experience chest pain and dizziness.

Ms. Engle has always been an active person. As a child, she competed in diving, cheerleading, and gymnastics, and even did gymnastics at club level through college. After graduation, she stayed active while working in Arlington, Virginia through CrossFit, weight lifting, and 5K running to encourage people to get into the STEM areas – science, technology, engineering, and math.

Categories
Health

Here is what you could know the lambda variant

Here's what you need to know the lambda variant

Health workers vaccinate a woman in Peru.

DIEGO RAMOS | AFP | Getty Images

More than 18 months after the Covid-19 pandemic, the world is now used to news of new variants of the virus, especially those that have successively supplanted previous versions of the disease.

Some mutations of the virus, such as the alpha variant and the delta variant – first discovered in the UK and India respectively – were more transmissible than previous iterations of the virus and have gained worldwide acceptance. Whenever a new variant of the coronavirus emerges, scientists keep a close eye on it.

While the world is still grappling with the rapid spread of the delta variant, which the alpha variant has usurped in terms of portability and hospital admissions for unvaccinated people, there is now a new variant that is being watched by experts: the lambda -Variant.

Here’s what we know (and don’t know) about:

What is the lambda variant?

The lambda variant, or “C.37” as the lineage was called, has spread rapidly in South America, particularly Peru, where the earliest documented samples of the virus are from August 2020.

However, it was only marked as an “interesting variant” by the World Health Organization on June 14 of this year, as cases attributed to the variant had noticeably spread.

In its mid-June report, the WHO reported that “lambda has been linked to significant transmission rates in the community in several countries, with prevalence increasing over time as the incidence of Covid-19 increases” and that further research is needed this topic would be carried out variant.

Where is it exactly?

The WHO found in its June 15 report that the lambda variant was found in 29 countries, territories or areas in five WHO regions, although it is more prevalent in South America.

“Authorities in Peru reported that 81% of the Covid-19 cases sequenced since April 2021 were linked to lambda. Argentina reported an increasing prevalence of lambda since the third week of February 2021, and between April 2 and May 19 In 2021, the variant accounted for 37% of the Covid-19 cases sequenced, ”the WHO stated.

Meanwhile, in Chile, the prevalence of lambda has increased over time, accounting for 32% of the sequenced cases reported in the past 60 days, the WHO said, adding that it was floating around at rates similar to the gamma variant be, but “out competition” of the alpha variant in the same period.

According to Public Health England, the lambda variant had been detected in cases in 26 countries by June 24. These included Chile, Argentina, Peru, Ecuador, Brazil and Colombia as well as the USA, Canada, Germany, Spain, Israel, France, Great Britain and Zimbabwe.

Is it more dangerous?

The WHO and other public health authorities are trying to understand how the variant compares to other strains of the virus, including whether it could be more transmissible and more resistant to vaccines.

In mid-June, the WHO announced that “Lambda carries a number of mutations with suspected phenotypic implications, such as a potentially increased transferability or a possible increased resistance to neutralizing antibodies”.

Recalling the specific mutations in the spike protein (some of which have been described by experts as unusual), WHO said “There is currently limited evidence of the full extent of the effects associated with these genomic changes” and further studies are needed. “to better understand the impact on countermeasures [against Covid-19] and control the spread. “

It is important to note that the lambda variant is still one step down and is referred to as a “questionable variant”, like the alpha or delta mutations. In a press conference last week, the WHO technical director on Covid-19, Dr. Maria Van Kerkhove, asked what would have to happen in order to change her definition of the lambda variant.

“It would be worrying if it showed ways of increased portability, for example if it has increased severity or if it has some sort of impact on our countermeasures,” she said.

Do vaccines work against this?

Here, too, further studies are required on the effect of the lambda variant on the effectiveness of vaccines, especially in the case of vaccines widely used in the West such as those from Pfizer-BioNTech, Moderna or Oxford-AstraZeneca.

However, in parts of South America, questions have been raised about the effectiveness of Chinese vaccines, which have been used primarily in the region, as cases related to the spread of the lambda variant and infection rates rise alongside vaccination programs. Brazil, Chile and Peru all rely heavily on the Chinese Covid vaccines Sinovac or Sinopharm, but vaccination rates vary widely in South America.

Categories
Health

Research Particulars How Delta Variant Dodges Immune System

Study Details How Delta Variant Dodges Immune System

The delta variant of the coronavirus can evade antibodies that target specific parts of the virus, according to a new study published in Nature on Thursday. The results provide an explanation for the reduced effectiveness of the vaccines against Delta compared to other variants.

The variant first identified in India is believed to be about 60 percent more contagious than Alpha, the version of the virus that hit Britain and much of Europe earlier this year, and perhaps twice as contagious as the original coronavirus. The delta variant is now causing outbreaks among unvaccinated populations in countries like Malaysia, Portugal, Indonesia and Australia.

Delta is now also the dominant variant in the USA. Infections in the country have been at their lowest level since the pandemic began, although the numbers may rise. Still, hospital admissions and deaths related to the virus remain steep. That’s partly because of the relatively high vaccination rates: 48 percent of Americans are fully vaccinated and 55 percent have received at least one dose.

But the new study found that Delta was barely sensitive to a dose of the vaccine, confirming previous research suggesting the variant can partially bypass the immune system – albeit to a lesser extent than Beta, the variant first identified in South Africa.

French researchers tested how well antibodies produced by natural infections and by coronavirus vaccines neutralize the alpha, beta and delta variants, as well as a reference variant that is similar to the original version of the virus.

The researchers examined blood samples from 103 people infected with the coronavirus. Delta was much less sensitive than Alpha to samples from unvaccinated individuals in this group, the study found.

One dose of vaccine increased sensitivity significantly, suggesting that people who have recovered from Covid-19 may still need to be vaccinated to fight off some variants.

The team also analyzed samples from 59 people after receiving the first and second doses of the AstraZeneca or Pfizer-BioNTech vaccines.

Blood samples from just 10 percent of those immunized with a dose of the AstraZeneca or Pfizer-BioNTech vaccines were able to neutralize the Delta and Beta variants in laboratory tests. But a second dose increased that number to 95 percent. There was not much difference in the levels of antibodies produced by the two vaccines.

“A single dose of Pfizer or AstraZeneca was either poorly effective or not effective at all against beta and delta variants,” the researchers concluded. Data from Israel and the UK broadly support this finding, although these studies suggest that one dose of vaccine is still enough to prevent hospitalization or death from the virus.

According to the new study, the Delta variant also did not react to Bamlanivimab, the monoclonal antibody from Eli Lilly. Fortunately, three other monoclonal antibodies tested in the study retained their effectiveness against the variant.

In April, the US Food and Drug Administration revoked the emergency approval for the treatment of Covid-19 patients as a single treatment, citing the increase in variants resistant to bamlanivimab.

Separately, Pfizer announced Thursday that it is developing a version of its vaccine that targets the Delta variant and is expected to begin clinical trials in August.

The company also reported promising results from studies of people who received a third dose of the original vaccine. A booster given six months after the second dose increases the effectiveness of the antibodies against the original virus and beta variant by five to ten times, the company said in a press release.

Antibody levels could drop six months after immunization, Pfizer said, and booster doses may be needed to fight off variants. But antibodies aren’t the only part of the body’s immune response, and other studies have shown that the immunity induced by full vaccination is likely to remain robust against variants for years to come.

Categories
Health

Warfare, Covid and local weather change gasoline starvation disaster killing 11 each minute

War, Covid and climate change fuel hunger crisis killing 11 every minute

After a fire in a refugee camp in Ukhia in the southeastern district of Cox’s Bazar on March 24, 2021, children are seen eating food provided by NGOs and social organizations.

Yousuf Tushar | LightRakete | Getty Images

LONDON – According to a new Oxfam report released on Friday, the number of people who died of starvation increased six-fold over the past year to surpass deaths from Covid-19.

Up to 11 people die of starvation and malnutrition every minute as the proportion of people suffering from starvation-like conditions has skyrocketed since the pandemic began, the global charity said in a paper titled “The Hunger Virus Multiplies” .

For comparison: an estimated 7 people die of Covid-19 every minute.

The statistics are overwhelming, but we must remember that these numbers are individual people who are exposed to unimaginable suffering. One person is too much too.

Abby Maxman

President and CEO, Oxfam America

Main causes of extreme hunger

War and conflict remain the leading cause of hunger, accounting for two-thirds of hunger-related deaths worldwide. However, the outbreak of the coronavirus pandemic and economic shocks as a result of Covid-19, as well as the worsening climate crisis, have starved tens of millions, the report said.

Global food prices are also up 40%, the highest increase in more than 10 years, the report said.

“The statistics are mind-boggling, but we must remember that these numbers are made up of individuals exposed to unimaginable suffering. Even one person is too much, ”said Abby Maxman, President and CEO of Oxfam America.

A relative prays on a cremation site during the final rites of a Covid-19 victim.

Majority world | Universal picture group | Getty Images

Oxfam named war-torn countries like Afghanistan, Ethiopia, South Sudan, Syria and Yemen among the world’s worst hunger hotspots.

“Hunger continues to be used as a weapon of war to steal food and water from civilians and to hamper humanitarian aid,” said Maxman. “People cannot live safely or find food when their markets are bombed and crops and livestock are destroyed.”

Meanwhile, food insecurity has worsened in what the charity has dubbed “emerging epicentres of hunger” such as India, South Africa and Brazil – some of the countries hardest hit by Covid-19 infections.

But even countries with relatively resilient food systems like the US have been rocked by the pandemic and recent climate shocks, the report said.

Hurt the most vulnerable people

In any case, vulnerable groups like women, displaced people and informal workers are hardest hit, Maxman said.

“Marginalized groups are hardest hit by conflict and hunger. Too often women and girls eat last and least. ” She said.

Governments must prevent conflict from fueling catastrophic hunger.

Abby Maxman

President and CEO, Oxfam America

The spike in hunger-related deaths comes in a year when global military spending rose by $ 51 billion – enough to cover six and a half times what the United Nations believes it needs to stop hunger.

Meanwhile, the world’s 10 richest people have risen by $ 413 billion in net worth over the past year – 11 times the estimated cost of the United Nations for global humanitarian aid.

“Governments must prevent conflict from fueling catastrophic hunger and instead ensure that aid agencies reach those in need,” Maxman said, calling for multilateral support from policymakers.

“We need the US to take a leadership role in ending this hunger crisis by pushing for an end to the conflicts that fuel this famine, providing the vital resources to save lives now, and helping communities achieve a safe one Building the future. “

Categories
Health

A New Alzheimer’s Drug Gives Extra Questions Than Solutions

A New Alzheimer’s Drug Offers More Questions Than Answers

“It puts us in a bad place,” agreed Dr. Karina Bishop, a geriatrician at the University of Nebraska Medical Center. Ethically, she added, “if this drug was available right now, I would not feel able to prescribe it.”

Even as individual doctors grapple with advising patients, hospitals and health systems are devising protocols for when Aduhelm becomes available, probably within weeks.

At the Mayo Clinic, said Dr. Ronald Petersen, a neurologist who directs the Alzheimer’s Disease Research Center there, “we’re going to stick pretty close to the inclusion and exclusion criteria used in the trial.”

That means only patients with mild cognitive impairment or early Alzheimer’s disease would qualify, after an M.R.I. to rule out certain conditions and risks, and a P.E.T. scan or lumbar puncture to confirm the presence of amyloid. The Mayo protocols, like the clinical trials, would exclude people taking blood thinners like Warfarin or Eliquis.

“It’s not like you come in and say, ‘I’m a little forgetful,’ and we say, ‘Here’s this drug,’” said Dr. Petersen. But not every provider, he acknowledged, will employ such safeguards.

Dr. Eric Widera, a geriatrician at the University of California, San Francisco, expressed a similar concern: “If doctors were extremely cautious and limited this drug to the very specific population included in the study, with very careful monitoring, it would be the first time in medicine that was ever done.”

He pointed out another consequence of federal approval: a rift between some doctors and the Alzheimer’s Association, the national advocacy group, which this spring mounted a campaign it called More Time. Intended to demonstrate public support for approval of aducanumab, the effort included newspaper ads and social media posts.

Categories
Health

Pfizer says it’s growing a Covid booster shot to focus on the extremely transmissible delta variant

Pfizer says it is developing a Covid booster shot to target the highly transmissible delta variant

Pfizer and BioNTech announced Thursday that they are developing a Covid-19 booster vaccine that will target the Delta variant amid concerns about the highly communicable strain that is already the predominant form of the disease in the United States.

The companies said that while they believe a third vaccination of their current two-dose vaccine has the potential to maintain the “highest level of protection” against all currently known variants, including Delta, they are “vigilant” and are developing an updated version of the Vaccine.

“As evidenced by real evidence from the Israeli Ministry of Health, the effectiveness of the vaccine has declined six months after vaccination, while at the same time the Delta variant is becoming the dominant variant in the country,” the companies said in a written statement.

“These results are consistent with an ongoing analysis of the companies’ Phase 3 study,” they said. “This is why we have said, and continue to believe, that all of the data we have, it is likely that a third dose may be required within 6 to 12 months of full vaccination.”

Clinical trials could begin as early as August, subject to regulatory approvals, the companies said.

The announcement comes on the same day the Olympic Games organizers said they would be banning all viewers from the Games this year after Japan declared a state of emergency designed to stem a wave of new Covid-19 infections that are partly due to the Delta variant is due.

Delta is estimated by the World Health Organization to be about 55% more transmissible than Alpha, the variant first found in the UK that once dominated the US, didn’t do as well at protecting against mild illnesses and the spread of the disease to others, scientists say.

On Monday, Israeli officials reported a decrease in the effectiveness of the Pfizer BioNTech vaccine in preventing infections and symptomatic diseases, but said it remained highly effective in preventing serious diseases.

In the US, health officials are urging all eligible Americans to get vaccinated as soon as possible, especially before the fall season when Delta is expected to lead to a further surge in new coronavirus cases, especially in places with the lowest vaccination rates.

There are about 1,000 counties in the U.S. with a Covid vaccination rate of less than 30%, mostly located in the Southeast and Midwest, said CDC Director Dr. Rochelle Walensky recently. In these areas, the authority already sees increasing infection rates due to the further spread of the delta variant.

Pfizer and BioNtech executives have repeatedly said that people will likely need a booster vaccination or a third dose within 12 months of full vaccination, as they expect vaccine-induced immunity to wear off over time. They also said that people are likely to have to take extra shots every year.

Pfizer and BioNTech are developing booster vaccines and are expected to apply for US approval for a third dose of their vaccine shortly.

Categories
Health

In a Reversal, F.D.A. Requires Limits on Who Will get Alzheimer’s Drug

In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug

When the FDA approved Aduhelm a month ago, the original label said the drug was “for the treatment of Alzheimer’s disease.” The surprisingly broad label caused a storm of concern among many Alzheimer’s experts, even those who had supported the drug’s approval.

At a forum sponsored by the Alzheimer’s Association last month that urged Aduhelm to be approved, a panel of Alzheimer’s clinics with differing views agreed on whether the drug should have been approved that its use was strong should be restricted.

Many experts say the drug’s label should not only restrict Aduhelm’s use to mild disease stages, but also require two more stringent clinical trial conditions: that suitable patients have evidence of high levels of a key protein, amyloid, in their brain, and that people with certain diseases (so-called “contraindications”) should be prevented from taking the drug or at least classified as a high-risk group, as this can lead to brain swelling and bleeding.

At the forum, Dr. Stephen Selloway, director of the Memory and Aging Program at Butler Hospital in Providence, RI, who helped conduct the Aduhelm studies and is one of the drug’s most ardent medical advocates, when he saw the label had no contraindications to his The reaction was “oy”.

On Thursday, Dr. Lon Schneider, director of the California Alzheimer’s Disease Center at the University of Southern California, who also worked on one of the Aduhelm studies and spoke out against the approval of the drug, saying that the new labeling was neglected.

The label should have said, among other things, that people with diabetes, high blood pressure and people who take blood thinners are not allowed to take part in the clinical trials and therefore “no extent is known”. of increased risk ”for these patients.

Dr. Jason Karlawish, a co-director of the University of Pennsylvania’s Penn Memory Center, said the new label was based more on what he and other Alzheimer’s experts believe should originally have been written. But the abrupt revision of the label so soon after a much criticized approval decision was worrying, he said.

Categories
Health

U.S. heading for ‘harmful fall’ with surge in delta Covid instances and return of indoor masks mandates

U.S. heading for 'dangerous fall' with surge in delta Covid cases and return of indoor mask mandates

People wearing protective masks shop at a Walmart store in Hallandale Beach, Florida on May 18, 2021.

Joe Raedle | Getty Images

With the highly transmittable Delta-Covid variant continuing to spread rapidly in the United States and elsewhere around the world, scientists and other health experts are warning that indoor mask regulations and other public health measures in the US are likely to return this fall.

The country, which just celebrated July 4th with some of its first major gatherings in more than a year, is heading for a “dangerous” fall season, with Delta expected to cause another surge in new coronavirus cases, health experts say. Delta is already the predominant variant in the US and will hit the states with the lowest vaccination rates the hardest – unless those states and companies reintroduce mask rules, capacity limits, and other public health measures, which they largely withdrew in recent months have, say experts.

With new mutations discovered every few weeks, many scientists are now predicting that Covid will circulate around the world for at least the next two to three years, obliging nations to adopt ad hoc public health measures for the foreseeable future. Authorities in Australia, South Africa and Asia recently reinstated curfews or other measures to contain rising delta outbreaks. Japan has just declared a coronavirus emergency in Tokyo and banned spectators from the Olympic Games. High vaccination rates in the US and the warm summer months have bought the country a little more time, but outbreaks around the world are giving Americans a preview of what could come this fall.

Health workers chats near an ambulance in the parking lot of the Steve Biko Academic Hospital amid a coronavirus disease (COVID-19) nationwide lockdown in Pretoria, South Africa, Jan. 11, 2021.

Siphiwe Sibeko | Reuters

“I could foresee that in certain parts of the country mask requirements, distance and occupancy restrictions for indoor areas would be reintroduced in the coming months,” said Lawrence Gostin, director of the World Health Organization’s Cooperation Center for National and Global Health Law.

He fears there will be “major outbreaks” in the US this fall, especially in states with low vaccination rates.

“We are heading for a very dangerous fall, with large parts of the country still unvaccinated, a swelling Delta variant and people taking off their masks,” added Gostin.

The warning from scientists and other health professionals comes as many U.S. companies and offices have largely phased out mask requirements, social distancing, and other pandemic-related restrictions.

Almost immediately after the Centers for Disease Control and Prevention declared in mid-May that fully vaccinated people would not need to wear masks in most indoor spaces, Walmart and Costco followed suit, allowing fully vaccinated customers and employees without state or local laws. Similarly, the Detroit automakers and the United Auto Workers union agreed late last month to make face masks optional for fully vaccinated employees.

A General Motors assembly worker loads engine block castings onto the assembly line at the GM Romulus Powertrain plant in Romulus, Michigan, the United States, August 21, 2019.

Rebecca Cook | Reuters

Other companies like Apple and Amazon are urging most of their employees to return to the office in some capacity this fall as more Americans get vaccinated against the virus. Goldman Sachs employees returned to the office last month, while Citigroup and JPMorgan expect their employees to return on a rotation basis this month.

Confirmed Covid infections in the US have dropped to their lowest level since the pandemic began, averaging about 15,000 new cases per day for the past seven days from a high of about 251,000 average new cases per day in January, according to Johns Hopkins University. Hospital stays and deaths have also declined, with Covid deaths averaging around 225 per day – up from a high of an average of more than 3,400 deaths per day in January.

Should daily Covid cases pick up again in the fall, as expected by health professionals, some employers in states with low Covid vaccination rates may face the difficult decision to make public health measures such as wearing masks and social distancing capacities to reintroduce limits or send office workers home entirely.

There will be “two Americas,” said Dr. Paul Offit, a pediatrician and vaccine advocate who served on advisory boards for both the Centers for Disease Control and Prevention and the Food and Drug Administration. “There’s vaccinated America and unvaccinated America, and I think unvaccinated America will pay a price for that.”

There are about 1,000 counties in the U.S. with a Covid vaccination rate of less than 30%, mostly located in the Southeast and Midwest, said CDC Director Dr. Rochelle Walensky recently. In these areas, the authority already sees increasing infection rates due to the further spread of the delta variant.

This has led some state and local health authorities to reintroduce previously abandoned public health measures.

Patricia Cole receives a shot of the Moderna Covid-19 vaccination from a medical worker at a pop-up clinic operated by the Delta Health Center in that rural Delta community on April 27, 2021 in Hollandale, Mississippi.

Spencer Platt | Getty Images

For example, in Mississippi, where less than a third of the state’s eligible population is fully vaccinated, officials last week recommended that all residents continue to wear masks indoors as Delta becomes the predominant variety in the state. About 96% of the new Covid cases in Mississippi are unvaccinated, state health officials said when they called reporters.

White House senior medical advisor Dr. Anthony Fauci said that people in states like Mississippi, where transmission are high and vaccinations are low, may want to consider wearing masks even if they are fully vaccinated.

“Depending on your personal situation, that could be,” said Fauci in an interview that was held on Friday with SiriusXM’s “Doctor Radio Reports” with Dr. Marc Siegel is to be broadcast. “For example, someone who is an elderly person who may not have full robust protection even though the protection is very, very high, or someone with an underlying medical condition,” still wants to wear a mask, he said.

Anthony Fauci, director of the National Institute of Allergies and Infectious Diseases at the National Institutes of Health (NIH) testifies ahead of a Senate hearing on Health, Education, Labor and Pensions to receive an update from federal officials on efforts to fight COVID 19 to be examined in the Dirksen Senate Office Building on May 11, 2021 in Washington, DC.

Jim Lo Scalzo | Getty Images

Officials in Los Angeles County, California last week also recommended that “everyone, regardless of vaccination status,” wear masks as a precaution in public places indoors.

Offit, who advises the FDA on Covid vaccines, said he expected several more states to reintroduce indoor mask requirements this fall.

The United States is still “undervaccinated” and states with low vaccination rates are likely to be hit the worst, Offit said. Less than half of the United States, about 158 ​​million people, have been fully vaccinated, with more than a dozen states having fully immunized less than 40% of their population, according to CDC data. In Texas, the second most populous state after California, only 42% of residents are fully vaccinated, the data shows.

Even people who are fully protected have cause for concern when it comes to variants of Covid, Offit said. While the vaccines are good at protecting against serious illness and death, they may not protect as well against minor illness or the spread of Covid to others, he said. No vaccine is 100% effective, he noted.

“It is not a bold prediction to believe that SARS-CoV-2 will be circulating in two or three years. I mean, there are 195 countries out there, most of which haven’t received a single dose of vaccine. ”“ Offit said. “Will it still be circulating in the United States? I think that would be very, very likely.”

Dr. Christopher JL Murray, director of the Institute for Health Metrics and Evaluation, agreed that more states will need to re-implement mask mandates this fall. More vulnerable Americans may even have to wear masks every year during the peak covid and flu transmission season: November through April, he said. However, he noted that getting some Americans to wear face covers could be difficult now that the pandemic has subsided.

“Given the pandemic fatigue, getting most Americans to follow guidelines on mask use and social distancing will be more difficult. As cases and hospitalizations pick up again, maybe not until fall or winter, it might be easier to convince some. ” Take steps to be careful, “he said.

People crowd to eat at an outdoor restaurant as coronavirus disease (COVID-19) restrictions are eased on April 4, 2021 in Ann Arbor, Michigan, United States.

Emily Elconin | Reuters

Dr. Vin Gupta, a Harvard-trained lung specialist and NBC employee, said mask requirements should be reintroduced this fall, but should be enforced at the local level and with Covid vaccination rates and transmissions depending on events in the surrounding community.

“There has to be some specifics and multiple local jurisdictions have to make their own decisions, especially when the seasons shift and get back into cold, dry air,” he said.

Meanwhile, the federal government’s mask mandate for public transportation, including airplanes, commuter buses, and rail systems, is set to expire on September 13, unless the CDC renews it.

Whether the CDC does this is an open question, scientists said. Walensky and the White House have both advised there is no desire to reinstate the lockdowns and will leave much of the decisions about public health measures to the states.

“A lot of it isn’t science. It’s political science,” said Dr. Isaac Bogoch, professor of infectious diseases at the University of Toronto. “If you have a high rate of Covid-19 transmission in the community and you have a high rate of unvaccinated people, then from a scientific point of view it makes sense to mask indoor spaces. Whether or not this will go into policy is another question. “

Categories
Health

In search of Solutions on Covid, U.F.O.s and Sicknesses, Spy Businesses Flip to Scientists

Seeking Answers on Covid, U.F.O.s and Illnesses, Spy Agencies Turn to Scientists

But the recent challenges facing intelligence agencies have required a different range of scientific expertise, including some areas in which the authorities have invested fewer resources over the years.

“This is a really interesting moment where national security interests have shifted from some of the Cold War interests,” said Sue Gordon, a former top intelligence official. “The priorities are changing now.”

Given not only the immediate unresolved security issues, but also the longer-term challenge of improving the gathering of information on climate change, Avril D. Haines, director of the National Intelligence Service, has urged authorities to provide undergraduate and postgraduate students with extensive scientific knowledge.

“The DNI believes that the changing threat landscape requires intelligence agencies to develop and invest in a talented workforce, including those with scientific and technological backgrounds,” said Matt Lahr, a spokesman for Ms. Haines. “Without this know-how, we will not only not be competitive, but also not master the challenges we are facing today.”

Officials are also trying to make wider use of existing initiatives. For example, Ms. Haines’ office has been more aggressively questioning its Science and Technology Expert Group, a group of about 500 scientists who volunteer to help intelligence agencies answer scientific problems.

Officials have asked these scientists about coronavirus mutations, as well as climate change and the availability of natural resources. While the experts in the expert group do not conduct intelligence analysis, their answers can help such analysts within the agencies draw more precise conclusions, intelligence officials said.

In other cases, the efforts to bring in external expertise are new.

During the Trump administration, the State Department hired the National Academies of Sciences, Engineering and Medicine to investigate Havana Syndrome. The report concluded that a microwave weapon was a likely cause of many of the incidents but was hampered in part due to a lack of access to information; Not all material collected by the secret services was made available to scientists, officials said.

Categories
Health

New Covid outbreaks a high danger to financial restoration, OECD chief says

New Covid outbreaks a top risk to economic recovery, OECD chief says

Covid-19 vaccinations without prior registration will be given at Sector 30 District Hospital in Noida, India on June 22, 2021.

Sunil Ghosh | Hindustan times | Getty Images

New outbreaks of Covid-19 remain one of the greatest risks to a global economic recovery, warned the Secretary-General of the OECD, calling on developed countries to support less developed countries with their vaccination programs.

“We have to do what we can to get as many people as possible around the world to vaccinate. There is a special responsibility for developed economies and it is not just about charity or charity, it is actually both a matter of self-interest “to keep our people safe … and to ensure that economic recovery is sustainable” said Mathias Cormann, Secretary General of the OECD, on Thursday.

“New outbreaks are still one of the biggest downside risks to the ongoing economic recovery,” he told CNBC’s Annette Weisbach.

“There is a race between vaccinating as many people as possible around the world, including and especially in developing countries, and the risk of new variants emerging and variants that may be resistant to the vaccines currently available,” he noted.

Read more: Covid-19 has destroyed 22 million jobs in advanced countries, according to the OECD

It is not only Cormann who fears that the continued spread of Covid-19, especially the latest highly transmissible Delta variant in younger and unvaccinated people, could destroy an economic recovery.

French Finance Minister Bruno Le Maire told CNBC on Tuesday that “the only thing that could jeopardize France’s economic recovery is a new wave of the pandemic”.

On Wednesday, the World Health Organization reiterated its call for wealthy nations to help poorer countries by sharing Covid vaccines, especially for health and care workers and the elderly.

Global minimum tax rate

The coronavirus pandemic may be the most pressing problem for global public health, but governments have now turned to other pressing matters, including international tax reform.

In June, treasury ministers from the most advanced economies known as the Group of Seven backed a US proposal requiring companies around the world to pay at least 15% income tax.

Last Thursday, US Treasury Secretary Janet Yellen announced that at least 130 nations had agreed to a global minimum tax on companies, part of a broader agreement to revise international tax rules.

Cormann said the deal was urgently needed, noting that “131 countries have reached an agreement on an internationally consistent path to fair taxation. Globalization and the digitization of our economies led to efficiency distortions and serious inequalities in our tax system and companies did not pay their fair share of taxes where they should. “

“We now have an agreement whereby the winners of globalization, including and especially the major digital multinationals, would pay their fair share of taxes or pay their fair share of taxes once (the deal) was in the markets in which they operate are implemented. “Their profits.”

He noted that all 131 countries have agreed that the global minimum corporate tax rate should be 15%, as have those in the group of 20 developed countries. “This underpins tax competition worldwide.”

Some low corporate tax countries like Ireland and Hungary have concerns about the deal, but Cormann said they were involved in the negotiation process: “Some countries seem to be starting from a different position,” he noted, “but 131 out of 139”. Counties (members of the G20 / OECD Inclusive Framework working together on tax reform) are on board and this is an important milestone. “